23 CALCIUM THERAPY CAUSES PROGRESSION OF CORONARY STENOSIS IN TYPE A WOMEN.

Our pilot study (PS) shows calcium therapy (Rx) causes systolic hypertension (SBP > 120 mm Hg) and coronary stenosis (CS) in type A women (TA) on calcium hormonal replacement therapy (CHRRx). Low systolic time intervals (STI p t -test = TT) rise in pulse pressure (PP) to handgrip (RPPHG > 15 mm Hg at 5 PSI, 3 minutes). Both identify high adrenergic neurovascular tone (ANVT with STI = PEP/LVET × 100%). STI predicted TA behavior test results ( r = .98, p 1c 13, normal serum tryglycerides ( p p p 120) and high SVR are significant vascular risk factors during CHRRx in TA women. Thus, control of SBP ( 45) is necessary for the prevention or regression of AC and %CS during calcium Rx.